Solvay SA and RahuCat Agree Collaboration Deal

October 2007

The world’s leading peroxide hydrogen producer, Belgian based Solvay SA, has agreed a long term technical collaboration deal with RahuCat targeting the selective development of activated oxidation and bleaching processes.

The deal provides a platform for using Dragon activators and catalysts to improve peroxide hydrogen performance in three important markets. Development is aimed at peroxide market growth through improved operating economics, expansion into new applications , and meeting future environmental regulation.

The technical programme will use R&D facilities at both companies, initially based in Europe, but could expand into fast growing markets as application opportunities arise.

Commenting on the deal, RahuCat CEO, Paul Smith, welcomed the opportunity to work with the world’s leading player in peroxide chemistry and the chance to “combine real strengths in proven technologies for new and existing markets in all global regions”.

ENDS.

Back to News

SOLVAY is an international chemical and pharmaceutical Group with headquarters in Brussels. It employs some 29,000 people in 50 countries. In 2006 its consolidated sales amounted to EUR 9.4 billion generated by its three activity sectors: Chemicals, Plastics and Pharmaceuticals. Solvay (Euronext: NYSE SOLBt.BE - Bloomberg: SOLB.BB - Reuters: SOLBt.BR) is listed on the NYSE Euronext stock exchange in Brussels. Details are available at www.solvay.com